Bergh A - Search Results

1

Plasma prolactin and prostate cancer risk: A prospective study.

Stattin P, Rinaldi S, Stenman UH, Riboli E, Hallmans G, Bergh A, Kaaks R. Stattin P, et al. Among authors: bergh a. Int J Cancer. 2001 May 1;92(3):463-5. doi: 10.1002/ijc.1191. Int J Cancer. 2001. PMID: 11291087

2

Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors.

Westin P, Stattin P, Damber JE, Bergh A. Westin P, et al. Among authors: bergh a. Am J Pathol. 1995 Jun;146(6):1368-75. Am J Pathol. 1995. PMID: 7778676 Free PMC article.

3

Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.

Brändström A, Westin P, Bergh A, Cajander S, Damber JE. Brändström A, et al. Among authors: bergh a. Cancer Res. 1994 Jul 1;54(13):3594-601. Cancer Res. 1994. PMID: 8012987

4

Prostate cancer in northern Sweden. Incidence, survival and mortality in relation to tumour grade.

Grönberg H, Bergh A, Damber JE, Jonsson H, Lenner P, Angström T. Grönberg H, et al. Among authors: bergh a. Acta Oncol. 1994;33(4):359-63. doi: 10.3109/02841869409098429. Acta Oncol. 1994. PMID: 8018366

5

Pretreatment p53 immunoreactivity does not infer radioresistance in prostate cancer patients.

Stattin P, Damber JE, Modig H, Bergh A. Stattin P, et al. Among authors: bergh a. Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):885-9. doi: 10.1016/0360-3016(96)00134-4. Int J Radiat Oncol Biol Phys. 1996. PMID: 8751397

6

Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptors.

Landström M, Eklöv S, Colosetti P, Nilsson S, Damber JE, Bergh A, Funa K. Landström M, et al. Among authors: bergh a. Int J Cancer. 1996 Aug 7;67(4):573-9. doi: 10.1002/(SICI)1097-0215(19960807)67:4<573::AID-IJC17>3.0.CO;2-8. Int J Cancer. 1996. PMID: 8759618

7

p53 immunoreactivity as prognostic marker for cancer-specific survival in prostate cancer.

Stattin P, Bergh A, Karlberg L, Nordgren H, Damber JE. Stattin P, et al. Among authors: bergh a. Eur Urol. 1996;30(1):65-72. doi: 10.1159/000474147. Eur Urol. 1996. PMID: 8854070

8

Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival.

Stattin P, Damber JE, Karlberg L, Nordgren H, Bergh A. Stattin P, et al. Among authors: bergh a. Urol Res. 1996;24(5):257-64. doi: 10.1007/BF00304774. Urol Res. 1996. PMID: 8931289

9

Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancer.

Stattin P, Damber JE, Karlberg L, Bergh A. Stattin P, et al. Among authors: bergh a. J Urol. 1997 Jan;157(1):219-22. J Urol. 1997. PMID: 8976256

10

Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats.

Zhang JX, Hallmans G, Landström M, Bergh A, Damber JE, Aman P, Adlercreutz H. Zhang JX, et al. Among authors: bergh a. Cancer Lett. 1997 Mar 19;114(1-2):313-4. doi: 10.1016/s0304-3835(97)04690-9. Cancer Lett. 1997. PMID: 9103319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

632 results

Search Page

Filters